소아의 구강내 하마종에서 Picibanil® 치료

초록

Background and Objectives：Although surgical excision has been considered to be the treatment of choice by most of the surgeons, sclerotherapy of ranula has gained popularity during recent years. A prospective clinical trial was conducted to evaluate the efficacy of Picibanil® sclerotherapies for treating ranula children. Subjects and Method：Three patients were enrolled in the study conducted during 2002. All patients were not hospitalized. Picibanil® was injected into the lesion. One girl and two boys with ages ranging from 8 to 12 years were treated. Results：Disappearance or marked reduction of the lesion and no recurrence of the ranula were observed in all children. Following each injection, local pain at the injection site was observed in 2 children and transient fever was observed in one child, but such problems resolved within a few days and no serious complication was developed. Conclusion：Our experience gives a suggestion that intralesional injection therapy using Picibanil® for intraoral ranula is relatively safe and can be used as a substitute for surgery in the treatment of ranula.

키워드